[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 520
Citations 0
News From the Food and Drug Administration
October 4, 2016

Evaluating Patients for Concussion

JAMA. 2016;316(13):1350. doi:10.1001/jama.2016.13803

Two new computerized tests that can help clinicians evaluate a patient’s cognitive function after a suspected brain injury or concussion have received FDA approval.

The Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) and ImPact Pediatric tests are intended for use as part of a medical evaluation rather than to diagnose a concussion or determine appropriate treatment, according to the FDA (http://bit.ly/2bZq6CU).

First Page Preview View Large
First page PDF preview
First page PDF preview
×